ВУЗ: Не указан
Категория: Не указан
Дисциплина: Не указана
Добавлен: 09.04.2024
Просмотров: 219
Скачиваний: 0
178 |
BRS Physiology |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
t a b l e |
|
5.9 |
Causes of Acid–Base Disorders |
|
|
|
|
|
|
|
|
|
|
|
Example |
Comments |
|
|
|
|
|
||
Metabolic acidosis |
Ketoacidosis |
Accumulation of β-OH-butyric acid and |
|
||
|
|
|
|
acetoacetic acid |
|
|
|
|
Lactic acidosis |
↑ anion gap |
|
|
|
|
Accumulation of lactic acid during hypoxia |
||
|
|
|
|
↑ anion gap |
|
|
|
|
Chronic renal failure |
Failure to excrete H+ as titratable acid and NH + |
|
|
|
|
|
↑ anion gap |
4 |
|
|
|
|
|
|
|
|
|
Salicylate intoxication |
Also causes respiratory alkalosis |
|
|
|
|
|
↑ anion gap |
|
|
|
|
Methanol/formaldehyde |
Produces formic acid |
|
|
|
|
intoxication |
↑ anion gap |
|
|
|
|
Ethylene glycol intoxication |
Produces glycolic and oxalic acids |
|
|
|
|
|
↑ anion gap |
|
|
|
|
Diarrhea |
GI loss of HCO3- |
|
|
|
|
|
Normal anion gap |
|
|
|
|
Type 2 RTA |
Renal loss of HCO - |
|
|
|
|
|
3 |
|
|
|
|
|
Normal anion gap |
|
|
|
|
Type 1 RTA |
Failure to excrete titratable acid and NH4+; failure |
|
|
|
|
|
to acidify urine |
|
|
|
|
|
Normal anion gap |
+ |
|
|
|
Type 4 RTA |
Hypoaldosteronism; failure to excrete NH |
|
|
|
|
|
4 |
|
|
|
|
|
Hyperkalemia caused by lack of aldosterone |
|
|
|
|
|
inhibits NH3 synthesis |
|
|
|
|
|
Normal anion gap |
|
Metabolic alkalosis |
Vomiting |
Loss of gastric H+; leaves HCO3- behind in blood |
|||
|
|
|
|
Worsened by volume contraction |
|
|
|
|
|
Hypokalemia |
|
|
|
|
|
May have ↑ anion gap because of production of |
|
|
|
|
|
ketoacids (starvation) |
|
|
|
|
Hyperaldosteronism |
Increased H+ secretion by distal tubule; increased |
|
|
|
|
|
new HCO3- reabsorption |
|
|
|
|
Loop or thiazide diuretics |
Volume contraction alkalosis |
|
Respiratory acidosis |
Opiates; sedatives; anesthetics |
Inhibition of medullary respiratory center |
|
||
|
|
|
Guillain-Barré syndrome; polio; |
Weakening of respiratory muscles |
|
|
|
|
ALS; multiple sclerosis |
↓ CO2 exchange in lungs |
|
|
|
|
Airway obstruction |
|
|
|
|
|
Adult respiratory distress |
↓ CO2 exchange in lungs |
|
|
|
|
syndrome; COPD |
|
|
Respiratory alkalosis |
Pneumonia; pulmonary embolus |
Hypoxemia causes ↑ ventilation rate |
|
||
|
|
|
High altitude |
Hypoxemia causes ↑ ventilation rate |
|
|
|
|
Psychogenic |
|
|
|
|
|
Salicylate intoxication |
Direct stimulation of medullary respiratory center; |
|
|
|
|
|
also causes metabolic acidosis |
|
ALS = amyotrophic lateral sclerosis; COPD = chronic obstructive pulmonary disease; GI = gastrointestinal; RTA = renal tubular acidosis.
2. Metabolic alkalosis
a. Loss of fixed H+ or gain of base produces an increase in arterial [HCO3-]. This increase is the primary disturbance in metabolic alkalosis.
■For example, in vomiting, H+ is lost from the stomach, HCO3− remains behind in the blood, and the [HCO3−] increases.
b. Increased HCO3− concentration causes an increase in blood pH (alkalemia).
c. Alkalemia causes hypoventilation, which is the respiratory compensation for metabolic alkalosis.
d. Correction of metabolic alkalosis consists of increased excretion of HCO3− because the filtered load of HCO3− exceeds the ability of the renal tubule to reabsorb it.
|
|
Chapter 5 Renal and Acid–Base Physiology |
179 |
||
100 |
|
|
|
|
|
80 |
|
|
|
|
|
60 |
|
|
|
|
|
(mm Hg) |
|
|
|
|
|
2 |
|
|
|
|
|
PCO |
|
|
|
|
|
40 |
|
|
|
|
|
20 |
|
|
|
|
|
0 |
|
|
|
|
|
0 |
12 |
24 |
36 |
48 |
60 |
|
|
[HCO3– ] (mEq/L) |
|
|
|
Figure 5.24 Acid–base map with values for simple acid–base disorders superimposed. The relationships are shown between arterial Pco2, [HCO3−], and pH. The ellipse in the center shows the normal range of values. Shaded areas show the range of values associated with simple acid–base disorders. Two shaded areas are shown for each respiratory disorder: one for the acute phase and one for the chronic phase. (Adapted with permission from Cohen JJ, Kassirer JP. Acid/ Base. Boston: Little, Brown; 1982.)
■If metabolic alkalosis is accompanied by ECF volume contraction (e.g., vomiting), the reabsorption of HCO3− increases (secondary to ECF volume contraction and activation of the renin–angiotensin II–aldosterone system), worsening the metabolic alkalosis (i.e., contraction alkalosis).
3. Respiratory acidosis
■ is caused by decreased alveolar ventilation and retention of CO2.
a. Increased arterial Pco2, which is the primary disturbance, causes an increase in [H+] and [HCO3-] by mass action.
b. There is no respiratory compensation for respiratory acidosis.
c. Renal compensation consists of increased excretion of H+ as titratable acid and NH4+ and increased reabsorption of “new” HCO3−. This process is aided by the increased Pco2, which supplies more H+ to the renal cells for secretion. The resulting increase in serum [HCO3−] helps to normalize the pH.
|
Renal and Acid–Base Physiology |
181 |
Chapter 5 |
d.Symptoms of hypocalcemia (e.g., tingling, numbness, muscle spasms) may occur because H+ and Ca2+ compete for binding sites on plasma proteins. Decreased [H+] causes increased protein binding of Ca2+ and decreased free ionized Ca2+.
X.dIuRETICs (TABlE 5.11)
XI. INTEGRATIVE EXAMPlEs
A.Hypoaldosteronism
1.Case study
■A woman has a history of weakness, weight loss, orthostatic hypotension, increased pulse rate, and increased skin pigmentation. She has decreased serum [Na+], decreased serum osmolarity, increased serum [K+], and arterial blood gases consistent with metabolic acidosis.
2.Explanation of hypoaldosteronism
a.The lack of aldosterone has three direct effects on the kidney: decreased Na+ reabsorption, decreased K+ secretion, and decreased H+ secretion. As a result, there is ECF volume contraction (caused by decreased Na+ reabsorption), hyperkalemia (caused by decreased K+ secretion), and metabolic acidosis (caused by decreased H+ secretion).
b.The ECF volume contraction is responsible for this woman’s orthostatic hypotension. The decreased arterial pressure produces an increased pulse rate via the baroreceptor mechanism.
|
|
|
|
|
||
t a b l e |
|
5.11 |
Effects of Diuretics on the Nephron |
|
||
|
|
|
|
|
|
|
Class of diuretic |
|
|
site of Action |
Mechanism |
Major Effect |
|
|
|
|
|
|||
Carbonic anhydrase |
Proximal tubule |
Inhibition of carbonic |
↑ HCO3- excretion |
|||
inhibitors (acetazolamide) |
|
anhydrase |
|
|||
Loop diuretics (furosemide, |
Thick ascending |
Inhibition of |
↑ NaCl excretion |
|||
ethacrynic acid, |
limb of the loop |
Na+–K+− 2Cl− |
↑ K+ excretion (↑ distal tubule |
|||
bumetanide) |
|
|
of Henle |
cotransport |
flow rate) |
|
|
|
|
|
|
|
↑ Ca2+ excretion (treat |
|
|
|
|
|
|
hypercalcemia) |
|
|
|
|
|
|
↓ ability to concentrate urine |
|
|
|
|
|
|
(↓ corticopapillary gradient) |
|
|
|
|
|
|
↓ ability to dilute urine |
|
|
|
|
|
|
(inhibition of diluting segment) |
Thiazide diuretics |
|
|
Early distal tubule |
Inhibition of |
↑ NaCl excretion |
|
(chlorothiazide, |
(cortical diluting |
Na+–Cl−cotransport |
↑ K+ excretion (↑ distal tubule |
|||
hydrochlorothiazide) |
segment) |
|
flow rate) |
|||
|
|
|
|
|
|
↓ Ca2+ excretion (treatment of |
|
|
|
|
|
|
idiopathic hypercalciuria) |
|
|
|
|
|
|
↓ ability to dilute urine |
|
|
|
|
|
|
(inhibition of cortical diluting |
|
|
|
|
|
|
segment) |
|
|
|
|
|
|
No effect on ability to |
|
|
|
|
|
|
concentrate urine |
K+-sparing diuretics |
Late distal tubule |
Inhibition of Na+ |
↑ Na+ excretion (small effect) |
|||
(spironolactone, |
and collecting |
reabsorption |
↓ K+ excretion (used in |
|||
triamterene, amiloride) |
duct |
Inhibition of K+ |
combination with loop or |
|||
|
|
|
|
|
secretion |
thiazide diuretics) |
|
|
|
|
|
Inhibition of H+ |
↓ H+ excretion |
secretion